Skip to main content

What the FDA labels say about taking them together

Canagliflozin and lithium

Canagliflozin's FDA label of June 11, 2026 names lithium in its drug interactions section; the lithium labels PlainMeds reads (4) do not name canagliflozin. The canagliflozin label: “Concomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations.”

Check it at the source: the canagliflozin FDA label on DailyMed (effective June 11, 2026, Janssen Pharmaceuticals, Inc.); the lithium FDA label on DailyMed (effective December 23, 2025, Glenmark Pharmaceuticals Inc., USA).

What does the canagliflozin label say about lithium?

Canagliflozin label, drug interactions

Clinical Impact: Concomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations. Intervention: Monitor serum lithium concentration more frequently during INVOKANA initiation and dosage changes. Drug/Laboratory Test Interference Positive Urine Glucose Test

Source: FDA drug label (INVOKANA), Janssen Pharmaceuticals, Inc., effective June 11, 2026 (SPL set b9057d3b-b104-4f09-8a61-c61ef9d4a3f3), via openFDA; the full label on DailyMed

What does the lithium label say about canagliflozin?

Lithium's label (effective December 23, 2025) and its 3 other brand-application labels do not name canagliflozin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lithium Carbonate), Glenmark Pharmaceuticals Inc., USA, effective December 23, 2025 (SPL set 63b3790f-a9b5-47f4-bae1-ddf8b43c13c1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Canagliflozin generic labelers
24Lithium generic labelers
CanagliflozinLithium
Labeled forHeart attack and coronary artery disease, Type 2 diabetes, Chronic kidney diseaseBipolar disorder
Boxed warningNoYes
Pharmacy cost (NADAC)$19.13 per tablet 100 mg tablet$0.104 per capsule 300 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?